| Prostate Cancer |
1 |
0.99 |
| Cancer |
0 |
0.85 |
| Biologic Therapy |
0 |
0.73 |
| Metastasis |
0 |
0.64 |
| Thyroid Disease |
0 |
0.52 |
| Prostate |
0 |
0.41 |
| Prostate Specific Antigen |
0 |
0.28 |
| Tumor |
0 |
0.27 |
| Biomedical Technology |
0 |
0.07 |
| Depression |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Surgery |
0 |
0.07 |
| Anxiety Disorder |
0 |
0.04 |
| Erectile Dysfunction |
0 |
0.04 |
| Patient Safety |
0 |
0.04 |
| Revenue and Practice Management |
0 |
0.04 |
| Accomodation |
0 |
0.03 |
| Adverse Effects |
0 |
0.03 |
| Antigens |
0 |
0.03 |
| Anxiety |
0 |
0.03 |
| Biopsy |
0 |
0.03 |
| Bladder |
0 |
0.03 |
| California |
0 |
0.03 |
| Dorsum |
0 |
0.03 |
| Insurance |
0 |
0.03 |
| Pennsylvania |
0 |
0.03 |
| Suicide |
0 |
0.03 |
| Thyroid |
0 |
0.03 |
| Tissue |
0 |
0.03 |
| Travel Medicine |
0 |
0.03 |